Cargando…
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
In the past 12 months a plethora of relevant novel data for the treatment of metastatic HER2 positive breast cancer were published. To bring this new evidence into a clinical perspective, a group of Austrian breast cancer specialists updated their previously published treatment algorithm for those p...
Autores principales: | Rinnerthaler, Gabriel, Singer, Christian, Petru, Edgar, Egle, Daniel, Petzer, Andreas, Pluschnig, Ursula, Gampenrieder, Simon Peter, Pfeiler, Georg, Gnant, Michael, Grünberger, Birgit, Krippl, Peter, Strasser-Weippl, Kathrin, Suppan, Christoph, Brunner, Christine, Pusch, Renate, Sandholzer, Margit, Balic, Marija, Bartsch, Rupert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606043/ https://www.ncbi.nlm.nih.gov/pubmed/36149495 http://dx.doi.org/10.1007/s00508-022-02082-3 |
Ejemplares similares
-
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2022) -
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
por: Gampenrieder, Simon Peter, et al.
Publicado: (2021) -
Capecitabine in combination with bendamustine in pretreated women
with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT
MBC-6)
por: Rinnerthaler, Gabriel, et al.
Publicado: (2021) -
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
por: Rinnerthaler, Gabriel, et al.
Publicado: (2018) -
Indications for liver transplantation in adults: Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX)
por: Graziadei, Ivo, et al.
Publicado: (2016)